Abstract
Epigenetic editing is a novel methodology to modify the epigenetic landscape of any genomic location. As such, the approach might reprogram expression profiles, without altering the DNA sequence. Epigenetic alterations, including promoter hypermethylation, are associated with an increasing number of human diseases. To exploit this situation, epigenetic editing rises as a new alternative to specifically demethylate abnormally hypermethylated regions. Here, we describe a methodology to actively demethylate the hypermethylated ICAM-1 promoter. Reducing DNA methylation in our target region increased the expression of the ICAM-1 gene. As the ICAM-1 gene in our cell lines was highly methylated (up to 80%), this approach proves a robust manner to reduce methylation for hypermethylated regions. Epigenetic editing therefore not only provides an approach to address mechanisms of gene expression regulation, but also adds to the therapeutic toolbox as current inhibitors of epigenetic enzymes are limited by genome-wide effects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wu C, Morris JR (2001) Genes, genetics, and epigenetics: a correspondence. Science 293:1103–1105
Fu Y, He C (2012) Nucleic acid modifications with epigenetic significance. Curr Opin Chem Biol 16:516–524
Suzuki Y, Korlach J, Turner SW, Tsukahara T, Taniguchi J, Qu W, Ichikawa K et al (2016) AgIn: measuring the landscape of CpG methylation of individual repetitive elements. Bioinformatics 32:2911–2919
Carninci P, Sandelin A, Lenhard B, Katayama S, Shimokawa K, Ponjavic J, Semple CA et al (2006) Genome-wide analysis of mammalian promoter architecture and evolution. Nat Genet 38:626–635
Kornblihtt AR (2006) Chromatin, transcript elongation and alternative splicing. Nat Struct Mol Biol 13:5–7
Aguilar JL, Montes A, Montero A, Vidal F, F-Llamazares J, Pastor C (1992) Continuous pleural infusion of bupivacaine offers better postoperative pain relief than does bolus administration. Reg Anesth 17:12–14
Saxonov S, Berg P, Brutlag DL (2006) A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc Natl Acad Sci U S A 103:1412–1417
De Smet C, Lurquin C, Lethe B, Martelange V, Boon T (1999) DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol 19:7327–7335
Edwards CA, Ferguson-Smith AC (2007) Mechanisms regulating imprinted genes in clusters. Curr Opin Cell Biol 19:281–289
Shen L, Kondo Y, Guo Y, Zhang J, Zhang L, Ahmed S, Shu J et al (2007) Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. PLoS Genet 3:2023–2036
Buck-Koehntop BA, Defossez PA (2013) On how mammalian transcription factors recognize methylated DNA. Epigenetics 8:131–137
Boyes J, Bird A (1991) DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell 64:1123–1134
He YF, Li BZ, Li Z, Liu P, Wang Y, Tang Q, Ding J et al (2011) Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333:1303–1307
Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, He C et al (2011) Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333:1300–1303
Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S et al (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324:930–935
Ito S, D’Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y (2010) Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466:1129–1133
Siddique AN, Nunna S, Rajavelu A, Zhang Y, Jurkowska RZ, Reinhardt R, Rots MG et al (2013) Targeted methylation and gene silencing of VEGF-A in human cells by using a designed Dnmt3a-Dnmt3L single-chain fusion protein with increased DNA methylation activity. J Mol Biol 425:479–491
Rivenbark AG, Stolzenburg S, Beltran AS, Yuan X, Rots MG, Strahl BD, Blancafort P (2012) Epigenetic reprogramming of cancer cells via targeted DNA methylation. Epigenetics 7:350–360
Falahi F, Huisman C, Kazemier HG, van der Vlies P, Kok K, Hospers GA, Rots MG (2013) Towards sustained silencing of HER2/neu in cancer by epigenetic editing. Mol Cancer Res 11:1029–1039
de Groote ML, Verschure PJ, Rots MG (2012) Epigenetic editing: targeted rewriting of epigenetic marks to modulate expression of selected target genes. Nucleic Acids Res 40:10596–10613
Uil TG, Haisma HJ, Rots MG (2003) Therapeutic modulation of endogenous gene function by agents with designed DNA-sequence specificities. Nucleic Acids Res 31:6064–6078
Thakore PI, Black JB, Hilton IB, Gersbach CA (2016) Editing the epigenome: technologies for programmable transcription and epigenetic modulation. Nat Methods 13:127–137
Tost J (2016) Engineering of the epigenome: synthetic biology to define functional causality and develop innovative therapies. Epigenomics 8:153–156
Cano-Rodriguez D, Rots MG (2016) Epigenetic editing: on the verge of reprogramming gene expression at will. Curr Genet Med Rep 4(4):170–179
Sangamo_BioSciences (2016) Sangamo BioSciences, Inc. Therapeutic applications. Hane Chow Inc. http://www.sangamo.com/technology/therapeutic-applications.html
Desjarlais JR, Berg JM (1992) Toward rules relating zinc finger protein sequences and DNA binding site preferences. Proc Natl Acad Sci U S A 89:7345–7349
Desjarlais JR, Berg JM (1993) Use of a zinc-finger consensus sequence framework and specificity rules to design specific DNA binding proteins. Proc Natl Acad Sci U S A 90:2256–2260
Choo Y, Klug A (1994) Toward a code for the interactions of zinc fingers with DNA: selection of randomized fingers displayed on phage. Proc Natl Acad Sci U S A 91:11163–11167
Egger G, Liang G, Aparicio A, Jones PA (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429:457–463
Zhang X, Zhang J, Wang R, Guo S, Zhang H, Ma Y, Liu Q et al (2016) Hypermethylation reduces the expression of PNPLA7 in hepatocellular carcinoma. Oncol Lett 12:670–674
Manoochehri M, Borhani N, Karbasi A, Koochaki A, Kazemi B (2016) Promoter hypermethylation and downregulation of the FAS gene may be involved in colorectal carcinogenesis. Oncol Lett 12:285–290
Robertson KD (2005) DNA methylation and human disease. Nat Rev Genet 6:597–610
Yang N, Eijsink JJ, Lendvai A, Volders HH, Klip H, Buikema HJ, van Hemel BM et al (2009) Methylation markers for CCNA1 and C13ORF18 are strongly associated with high-grade cervical intraepithelial neoplasia and cervical cancer in cervical scrapings. Cancer Epidemiol Biomark Prev 18:3000–3007
Huisman C, Wisman GB, Kazemier HG, van Vugt MA, van der Zee AG, Schuuring E, Rots MG (2013) Functional validation of putative tumor suppressor gene C13ORF18 in cervical cancer by Artificial Transcription Factors. Mol Oncol 7:669–679
Huisman C, van der Wijst MG, Falahi F, Overkamp J, Karsten G, Terpstra MM, Kok K et al (2015) Prolonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugs. Epigenetics 10:384–396
Huisman C, van der Wijst MG, Schokker M, Blancafort P, Terpstra MM, Kok K, van der Zee AG et al (2016) Re-expression of selected epigenetically silenced candidate tumor suppressor genes in cervical cancer by TET2-directed demethylation. Mol Ther 24:536–547
Chen H, Kazemier HG, de Groote ML, Ruiters MH, Xu GL, Rots MG (2014) Induced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter. Nucleic Acids Res 42:1563–1574
Magnenat L, Blancafort P, Barbas CF 3rd (2004) In vivo selection of combinatorial libraries and designed affinity maturation of polydactyl zinc finger transcription factors for ICAM-1 provides new insights into gene regulation. J Mol Biol 341:635–649
de Groote ML, Kazemier HG, Huisman C, van der Gun BT, Faas MM, Rots MG (2014) Upregulation of endogenous ICAM-1 reduces ovarian cancer cell growth in the absence of immune cells. Int J Cancer 134:280–290
Maeder ML, Angstman JF, Richardson ME, Linder SJ, Cascio VM, Tsai SQ, Ho QH et al (2013) Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins. Nat Biotechnol 31:1137–1142
Stolzenburg, S., Goubert, D., Rots, M. G. (2016) Rewriting DNA methylation signatures at will: the curable genome within reach? In: Jeltsch A., Jurkowska R. DNA methylation. Springer International Publishing, Switzerland. Adv Exp Med Biol 945:475–490
Segal DJ, Dreier B, Beerli RR, Barbas CF 3rd (1999) Toward controlling gene expression at will: selection and design of zinc finger domains recognizing each of the 5′-GNN-3′ DNA target sequences. Proc Natl Acad Sci U S A 96:2758–2763
Dreier B, Beerli RR, Segal DJ, Flippin JD, Barbas CF 3rd (2001) Development of zinc finger domains for recognition of the 5′-ANN-3′ family of DNA sequences and their use in the construction of artificial transcription factors. J Biol Chem 276:29466–29478
Dreier B, Fuller RP, Segal DJ, Lund CV, Blancafort P, Huber A, Koksch B et al (2005) Development of zinc finger domains for recognition of the 5′-CNN-3′ family DNA sequences and their use in the construction of artificial transcription factors. J Biol Chem 280:35588–35597
Bae KH, Kwon YD, Shin HC, Hwang MS, Ryu EH, Park KS, Yang HY et al (2003) Human zinc fingers as building blocks in the construction of artificial transcription factors. Nat Biotechnol 21:275–280
Maeder ML, Thibodeau-Beganny S, Osiak A, Wright DA, Anthony RM, Eichtinger M, Jiang T et al (2008) Rapid “open-source” engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol Cell 31:294–301
Liu PQ, Rebar EJ, Zhang L, Liu Q, Jamieson AC, Liang Y, Qi H et al (2001) Regulation of an endogenous locus using a panel of designed zinc finger proteins targeted to accessible chromatin regions. Activation of vascular endothelial growth factor A. J Biol Chem 276:11323–11334
Mandell JG, Barbas CF 3rd (2006) Zinc Finger Tools: custom DNA-binding domains for transcription factors and nucleases. Nucleic Acids Res 34:W516–W523
Corbi N, Perez M, Maione R, Passananti C (1997) Synthesis of a new zinc finger peptide; comparison of its ‘code’ deduced and ‘CASTing’ derived binding sites. FEBS Lett 417:71–74
Bulyk ML, Huang X, Choo Y, Church GM (2001) Exploring the DNA-binding specificities of zinc fingers with DNA microarrays. Proc Natl Acad Sci U S A 98:7158–7163
Meng X, Brodsky MH, Wolfe SA (2005) A bacterial one-hybrid system for determining the DNA-binding specificity of transcription factors. Nat Biotechnol 23:988–994
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Rendón, J.C., Cano-Rodríguez, D., Rots, M.G. (2017). Re-expressing Epigenetically Silenced Genes by Inducing DNA Demethylation Through Targeting of Ten-Eleven Translocation 2 to Any Given Genomic Locus. In: Kaufmann, M., Klinger, C., Savelsbergh, A. (eds) Functional Genomics. Methods in Molecular Biology, vol 1654. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7231-9_24
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7231-9_24
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7230-2
Online ISBN: 978-1-4939-7231-9
eBook Packages: Springer Protocols